News Conference News ESC 2019 New ‘Chronic Coronary Syndrome’ Guidelines Stress There’s Nothing Stable About CAD Shelley Wood August 31, 2019
News Conference News ESC 2017 CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events Michael O'Riordan August 27, 2017
News Conference News ESC 2016 Ezetimibe Plus Pitavastatin Fails to Lower Risk of CVD Events in ACS Patients: HIJ-PROPER Michael O'Riordan August 30, 2016
News Conference News ESC 2012 Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis Caitlin E. Cox August 29, 2012